Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · IEX Real-Time Price · USD
2.050
-0.480 (-18.97%)
At close: Apr 30, 2024, 4:00 PM
2.200
+0.150 (7.32%)
After-hours: Apr 30, 2024, 7:41 PM EDT
Barinthus Biotherapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for BRNS stock has a target of 8.00, which predicts an increase of 290.24% from the current stock price of 2.05.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for BRNS is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +290.24% | Apr 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +290.24% | Apr 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $8 | Strong Buy | Maintains | $15 → $8 | +290.24% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +631.71% | Nov 28, 2023 |
Financial Forecast
Revenue This Year
1.28M
from 802.00K
Increased by 58.98%
Revenue Next Year
1.70M
from 1.28M
Increased by 33.33%
EPS This Year
-2.20
from -1.91
EPS Next Year
-1.99
from -2.20
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 5.3M | 5.3M | 5.3M | n/a |
| Avg | 1.3M | 1.7M | 2.0M | n/a |
| Low | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 554.6% | 311.8% | 208.8% | - |
| Avg | 59.0% | 33.3% | 20.0% | - |
| Low | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -1.54 | -1.18 | -1.38 | -3.17 |
| Avg | -2.20 | -1.99 | -2.28 | -3.08 |
| Low | -2.63 | -2.81 | -3.57 | -2.96 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.